Negative toxicology urine control used to monitor and validate the performance o
Negative toxicology urine control used to monitor and validate the performance of PROFILE®-V MEDTOXScan® and MEDTOX® drugs of abuse test devices.
QC Test Devices used to detect errors associated with the MEDTOXScan® Reader and
QC Test Devices used to detect errors associated with the MEDTOXScan® Reader and a contaminated contact imaging sensor (CIS), and to verify that the CIS cleaning procedure using the MEDTOXScan® Cleaning Cassette effectively removed any contamination. QC Test Devices are intended to function as an optical performance system check for the MEDTOXScan® Reader only, and not intended to replace the need for external controls.
A qualitative one-step immunochromatographic test for the detection of Buprenorp
A qualitative one-step immunochromatographic test for the detection of Buprenorphine and/or metabolites in human urine.
A qualitative one-step immunochromatographic test panel for the detection of Can
A qualitative one-step immunochromatographic test panel for the detection of Cannabinoids (THC), Opiates, Amphetamines, Cocaine, Phencyclidine, Barbiturates, and Benzodiazepines drugs and/or metabolites in human urine.
A qualitative one-step immunochromatographic test panel for the detection of Can
A qualitative one-step immunochromatographic test panel for the detection of Cannabinoids (THC), Opiates, Amphetamines, Cocaine, Phencyclidine, Tricyclic Antidepressants, Barbiturates, Methadone, Benzodiazepines, Propoxyphene (PPX), Methamphetamine (MAMP), 3,4-Methylenedioxymethamphetamine (MDMA) and Oxycodone drugs and/or metabolites in human urine.
A qualitative one-step immunochromatographic test panel for the detection of Can
A qualitative one-step immunochromatographic test panel for the detection of Cannabinoids (THC), Opiates, Amphetamines, Cocaine, Phencyclidine, Tricyclic Antidepressants, Barbiturates, Methadone, Benzodiazepines, Propoxyphene (PPX), Methamphetamine (MAMP), 3,4 Methylenedioxymethamphetamine (MDMA) drugs and/or metabolites in human urine.
A qualitative one-step immunochromatographic test panel for the detection of Can
A qualitative one-step immunochromatographic test panel for the detection of Cannabinoids (THC), Opiates, Amphetamines, Cocaine, Tricyclic Antidepressants, Barbiturates, Methadone, Benzodiazepines, Propoxyphene (PPX), Methamphetamine (MAMP), 3,4-Methylenedioxymethamphetamine (MDMA) drugs and/or metabolites in human urine.
A qualitative one-step immunochromatographic test panel for the detection of Can
A qualitative one-step immunochromatographic test panel for the detection of Cannabinoids (THC), Opiates, Amphetamines, Cocaine, Phencyclidine, Tricyclic Antidepressants, Barbiturates, Methadone, and Benzodiazepines drugs and/or metabolites in human urine.
A qualitative one-step immunochromatographic test panel for the detection of C
A qualitative one-step immunochromatographic test panel for the detection of Cannabinoids (THC), Opiates, Cocaine, Methamphetamine (MAMP), 3,4-Methylenedioxymethamphetamine (MDMA) and Benzodiazepines drugs and/or their metabolites in human urine.
A qualitative one-step immunochromatographic test panel for the detection of Can
A qualitative one-step immunochromatographic test panel for the detection of Cannabinoids (THC), Opiates, Cocaine, Methamphetamine (MAMP), 3,4-Methylenedioxymethamphetamine (MDMA) drugs and/or their metabolites in human urine.
DJG,DJC,DIO,LDJ
Enzyme Immunoassay, Opiates,Thin Layer Chromatography, Methamphetamine,Enzyme Im
Enzyme Immunoassay, Opiates,Thin Layer Chromatography, Methamphetamine,Enzyme Immunoassay, Cocaine And Cocaine Metabolites,Enzyme Immunoassay, Cannabinoids
A qualitative one-step immunochromatographic test panel for the detection of Can
A qualitative one-step immunochromatographic test panel for the detection of Cannabinoids (THC), Opiates, Amphetamines, and Cocaine drugs and/or their metabolites in human urine.
A qualitative one-step immunochromatographic test panel for the detection of Can
A qualitative one-step immunochromatographic test panel for the detection of Cannabinoids (THC), Opiates, Amphetamines, Cocaine, and Methamphetamine (MAMP), 3,4-Methylenedioxymethamphetamine (MDMA) drugs and/or their metabolites in human urine.
A qualitative one-step immunochromatographic test panel for the detection of Can
A qualitative one-step immunochromatographic test panel for the detection of Cannabinoids (THC), Opiates, Amphetamines, Cocaine, Methamphetamine (MAMP), 3,4-Methylenedioxymethamphetamine (MDMA) and/or their metabolites in human urine.
A qualitative one-step immunochromatographic test panel for the detection of C
A qualitative one-step immunochromatographic test panel for the detection of Cannabinoids (THC), Opiates, Amphetamines, Cocaine, and Benzodiazepines drugs and/or their metabolites in human urine.
A qualitative one-step immunochromatographic test for the detection of Methadone
A qualitative one-step immunochromatographic test for the detection of Methadone in human urine.
A qualitative one-step immunochromatographic test for the detection of Tricyclic
A qualitative one-step immunochromatographic test for the detection of Tricyclic Antidepressants and/or metabolites in human urine.
A qualitative one-step immunochromatographic test for the detection of Benzodiaz
A qualitative one-step immunochromatographic test for the detection of Benzodiazepines and/or metabolites in human urine.
A qualitative one-step immunochromatographic test panel for the detection of Can
A qualitative one-step immunochromatographic test panel for the detection of Cannabinoids (THC), Opiates, Amphetamines, Cocaine, Phencyclidine, Barbiturates, and Benzodiazepines drugs and/or metabolites in human urine.
A qualitative one-step immunochromatographic test for the detection of Methamphe
A qualitative one-step immunochromatographic test for the detection of Methamphetamine, MDMA and/or metabolites in human urine.
A qualitative one-step immunochromatographic test panel for the detection of Can
A qualitative one-step immunochromatographic test panel for the detection of Cannabinoids (THC), Opiates, Amphetamines, Cocaine, and Phencyclidine drugs and/or their metabolites in human urine.
A qualitative one-step immunochromatographic test panel for the detection of Can
A qualitative one-step immunochromatographic test panel for the detection of Cannabinoids (THC), Opiates, Amphetamines, and Cocaine drugs and/or their metabolites in human urine.
A qualitative one-step immunochromatographic test panel for the detection of C
A qualitative one-step immunochromatographic test panel for the detection of Cannabinoids (THC) and Cocaine and/or their metabolites in human urine.
DKE,DIO
Reagents, Test, Tetrahydrocannabinol,Enzyme Immunoassay, Cocaine And Cocaine Metabolites
A qualitative one-step immunochromatographic test for the detection of Opiates a
A qualitative one-step immunochromatographic test for the detection of Opiates and/or metabolites in human urine.
A qualitative one-step immunochromatographic test for the detection of Cocaine a
A qualitative one-step immunochromatographic test for the detection of Cocaine and/or metabolites in human urine.
DIO
Enzyme Immunoassay, Cocaine And Cocaine Metabolites
A qualitative one-step immunochromatographic test for the detection of Cannabino
A qualitative one-step immunochromatographic test for the detection of Cannabinoids (THC) and/or metabolites in human urine.
A micro pipette designed to dispense an accurate volume of sample for the PROFIL
A micro pipette designed to dispense an accurate volume of sample for the PROFILE®-V MEDTOXScan® Test Devices.
Positive toxicology urine control used to monitor and validate the performance o
Positive toxicology urine control used to monitor and validate the performance of PROFILE®-V MEDTOXScan® drugs of abuse test devices.
Positive toxicology urine control used to monitor and validate the performance o
Positive toxicology urine control used to monitor and validate the performance of PROFILE®-V MEDTOXScan® drugs of abuse test devices.
Positive toxicology urine control used to monitor and validate the performance o
Positive toxicology urine control used to monitor and validate the performance of PROFILE®-V MEDTOXScan® drugs of abuse test devices.
Positive toxicology urine control used to monitor and validate the performance o
Positive toxicology urine control used to monitor and validate the performance of PROFILE®-V MEDTOXScan® drugs of abuse test devices.
A qualitative one-step immunochromatographic test panel for the detection of Can
A qualitative one-step immunochromatographic test panel for the detection of Cannabinoids (THC), Opiates, Amphetamine, Cocaine, Phencyclidine, Barbiturates, Benzodiazepines, Oxycodone, Methamphetamine (MAMP), 3,4-Methylenedioxymethamphetamine (MDMA), and Propoxyphene drugs and/or their metabolites in human urine.
A qualitative one-step immunochromatographic test panel for the detection of Can
A qualitative one-step immunochromatographic test panel for the detection of Cannabinoids (THC), Opiates, Amphetamines, Cocaine, Phencyclidine, Barbiturates and Benzodiazepines and/or their metabolites in human urine.
A qualitative one-step immunochromatographic test panel for the detection of Can
A qualitative one-step immunochromatographic test panel for the detection of Cannabinoids (THC), Opiates, Amphetamines, Cocaine, and Phencyclidine drugs and/or their metabolites in human urine.
A qualitative one-step immunochromatographic test panel for the detection of Can
A qualitative one-step immunochromatographic test panel for the detection of Cannabinoids (THC), Opiates, Amphetamines, Cocaine, Phencyclidine, Methamphetamine (MAMP), 3,4-Methylenedioxymethamphetamine (MDMA) and Oxycodone drugs and/or their metabolites in human urine.
An instrument used to interpret and report the results of the PROFILE®-V MEDTOXS
An instrument used to interpret and report the results of the PROFILE®-V MEDTOXScan® Test Devices, which are one-step immunochromatographic tests for the rapid, qualitative detection of one or more drugs in human urine.
JJQ
Colorimeter, Photometer, Spectrophotometer For Clinical Use
A qualitative one-step immunochromatographic test panel for the detection of THC
A qualitative one-step immunochromatographic test panel for the detection of THC (Cannabinoids), Phencyclidine, Cocaine, Methamphetamine (MAMP), Opiates, Amphetamine, Benzodiazepines, Methadone, Barbiturates, and Oxycodone drugs and/or metabolites in human urine.
A qualitative one-step immunochromatographic test panel for the detection of THC
A qualitative one-step immunochromatographic test panel for the detection of THC (Cannabinoids), Phencyclidine, Cocaine, Methamphetamine (MAMP), Opiates, Amphetamine, Benzodiazepines, Tricyclic Antidepressants, Methadone, Barbiturates, Oxycodone, Propoxyphene, and Buprenorphine drugs and/or metabolites in human urine.
A qualitative one-step immunochromatographic test panel for the detection of THC
A qualitative one-step immunochromatographic test panel for the detection of THC (Cannabinoids), Phencyclidine, Cocaine, Opiates, Amphetamine, Benzodiazepines, and Barbiturates drugs and/or metabolites in human urine.
A qualitative one-step immunochromatographic test panel for the detection of THC
A qualitative one-step immunochromatographic test panel for the detection of THC (Cannabinoids), Phencyclidine, Cocaine, Opiates, Amphetamine, Benzodiazepines, Tricyclic Antidepressants, Methadone, and Barbiturates drugs and/or metabolites in human urine.
A qualitative one-step immunochromatographic test panel for the detection of THC
A qualitative one-step immunochromatographic test panel for the detection of THC (Cannabinoids), Phencyclidine, Cocaine, Methamphetamine (MAMP), Opiates, Amphetamine, Benzodiazepines, Tricyclic Antidepressants, Methadone, Barbiturates, Oxycodone, and Propoxyphene drugs and/or metabolites in human urine.
A qualitative one-step immunochromatographic test panel for the detection of Amp
A qualitative one-step immunochromatographic test panel for the detection of Amphetamine, Barbiturates, Buprenorphine, Benzodiazepines, Cocaine, Methamphetamine, Methadone, Opiates, Oxycodone, Phencyclidine, Propoxyphene, and THC (cannabinoids) drugs and/or their metabolites in human urine.
A qualitative one-step immunochromatographic test panel for the detection of Amp
A qualitative one-step immunochromatographic test panel for the detection of Amphetamine, Cocaine, Methamphetamine, Opiates, Phencyclidine, and THC (cannabinoids) drugs and/or their metabolites in human urine.
A qualitative one-step immunochromatographic test panel for the detection of Amp
A qualitative one-step immunochromatographic test panel for the detection of Amphetamine, Benzodiazepines, Cocaine, Methamphetamine, Opiates, Oxycodone, and THC (Cannabinoids) drugs and/or their metabolites in human urine.
A rapid screening test system for the detection of Amphetamine, Benzodiazepines,
A rapid screening test system for the detection of Amphetamine, Benzodiazepines, Cocaine, Opiates, and THC (Cannabinoids) drugs and/or their metabolites in human urine.
Positive toxicology urine control used to monitor and validate the performance o
Positive toxicology urine control used to monitor and validate the performance of MEDTOX® drugs of abuse test devices.
Positive toxicology urine control used to monitor and validate the performance o
Positive toxicology urine control used to monitor and validate the performance of MEDTOX® drugs of abuse test devices.
Chemtrue 12-Panel DOA Cup Test, AMP/BAR/BUP/BZO/COC150/MDMA/MET/MTD/OPI/OXY/PCP/
Chemtrue 12-Panel DOA Cup Test, AMP/BAR/BUP/BZO/COC150/MDMA/MET/MTD/OPI/OXY/PCP/THC + A-strip (Cr/Ox/pH)
12-panel DOA Cup AMP500/BAR/BZO/COC150/MDMA/MET500/MTD/OPI300/OXY/PCP/PPX/THC (O
12-panel DOA Cup AMP500/BAR/BZO/COC150/MDMA/MET500/MTD/OPI300/OXY/PCP/PPX/THC (Ox/pH/SG) - PB
12-panel DOA Cup AMP500/BAR/BZO/COC150/MDMA/MET500/MTD/OPI300/OXY/PCP/PPX/THC (C
12-panel DOA Cup AMP500/BAR/BZO/COC150/MDMA/MET500/MTD/OPI300/OXY/PCP/PPX/THC (Cr/Ox/pH) - PB
The DRI™ Fentanyl II Assay (Thermo Fisher) is an immunoassay intended for the q
The DRI™ Fentanyl II Assay (Thermo Fisher) is an immunoassay intended for the qualitative determination of fentanyl in human urine at a cutoff concentration of 1.0 ng/mL.
The DRI™ Fentanyl II Assay is an immunoassay intended for the qualitative detec
The DRI™ Fentanyl II Assay is an immunoassay intended for the qualitative detection of fentanyl in human urine at a cutoff concentration of 1.0 ng/mL.
The ARK™ Fentanyl II Assay is a homogeneous enzyme immunoassay intended for the
The ARK™ Fentanyl II Assay is a homogeneous enzyme immunoassay intended for the qualitative determination of fentanyl in human urine at a cutoff concentration of 0.5 ng/mL. The assay provides a simple and rapid analytical screening procedure for detecting fentanyl in urine on automated clinical chemistry analyzers.
The ARK™ Fentanyl II Assay is an immunoassay intended for the qualitative deter
The ARK™ Fentanyl II Assay is an immunoassay intended for the qualitative determination of fentanyl in human urine at a cutoff concentration of 1.0 ng/mL.
The ARK™ Fentanyl II Assay is an immunoassay intended for the qualitative detec
The ARK™ Fentanyl II Assay is an immunoassay intended for the qualitative detection of fentanyl in human urine at a cutoff concentration of 1.0 ng/mL.
The ARK™ Fentanyl II Assay is an immunoassay intended for the qualitative deter
The ARK™ Fentanyl II Assay is an immunoassay intended for the qualitative determination of fentanyl in human urine at a cutoff concentration of 1.0 ng/mL.
The ARK™ Meperidine Assay is intended for the qualitative and/or semiquantitati
The ARK™ Meperidine Assay is intended for the qualitative and/or semiquantitative determination of meperidine in human urine at cutoff concentrations of 100 ng/mL. The assay is intended for use in laboratories with automated clinical chemistry analyzers. This in vitro diagnostic device is for prescription use only.
The ARK™ Meperidine Assay is intended for the qualitative and/or semiquantitati
The ARK™ Meperidine Assay is intended for the qualitative and/or semiquantitative determination of meperidine in human urine at cutoff concentrations of 100 ng/mL. The assay is intended for use in laboratories with automated clinical chemistry analyzers. This in vitro diagnostic device is for prescription use only.
Pointe 6-Acetylmorphine Reagent Set 1 x 1000 mL R1, 1 x 375 mL R2 The Pointe 6-A
Pointe 6-Acetylmorphine Reagent Set 1 x 1000 mL R1, 1 x 375 mL R2 The Pointe 6-Acetylmorphine Reagent Set is intended for the qualitative and semi-quantitative determination of 6-acetylmorphine in human urine at a cutoff value of 10 ng/mL. The assay is designed for prescription use with a number of automated clinical chemistry analyzers.
Pointe 6-Acetylmorphine Reagent Set 1 x 100 mL R1, 1 x 37.5 mL R2 The Pointe 6-A
Pointe 6-Acetylmorphine Reagent Set 1 x 100 mL R1, 1 x 37.5 mL R2 The Pointe 6-Acetylmorphine Reagent Set is intended for the qualitative and semi-quantitative determination of 6-acetylmorphine in human urine at a cutoff value of 10 ng/mL. The assay is designed for prescription use with a number of automated clinical chemistry analyzers.
Pointe Oxycodone Reagent Set 1 x 1000 mL R1, 1 x 375 mL R2 The Pointe Oxycodone
Pointe Oxycodone Reagent Set 1 x 1000 mL R1, 1 x 375 mL R2 The Pointe Oxycodone Reagent Set is intended for the qualitative and semi-quantitative determination of oxycodone in human urine, at cutoff values of 100 ng/mL and 300 ng/mL. The assay is designed for prescription use with a number of automated clinical chemistry analyzers.
Pointe Oxycodone Reagent Set 1 x 100 mL R1, 1 x 37.5 mL R2 The Pointe Oxycodone
Pointe Oxycodone Reagent Set 1 x 100 mL R1, 1 x 37.5 mL R2 The Pointe Oxycodone Reagent Set is intended for the qualitative and semi-quantitative determination of oxycodone in human urine, at cutoff values of 100 ng/mL and 300 ng/mL. The assay is designed for prescription use with a number of automated clinical chemistry analyzers.
Pointe Opiates 2000 Reagent Set 1 x 1000 mL R1, 1 x 375 mL R2 The Pointe Opiates
Pointe Opiates 2000 Reagent Set 1 x 1000 mL R1, 1 x 375 mL R2 The Pointe Opiates 2000 Reagent Set is intended for the qualitative and semi-quantitative determination of morphine in human urine at a cutoff value of 2000 ng/mL. The assay is designed for prescription use with a number of automated clinical chemistry analyzers.
Pointe Opiates 2000 Reagent Set 1 x 100 mL R1, 1 x 37.5 mL R2 The Pointe Opiates
Pointe Opiates 2000 Reagent Set 1 x 100 mL R1, 1 x 37.5 mL R2 The Pointe Opiates 2000 Reagent Set is intended for the qualitative and semi-quantitative determination of morphine in human urine at a cutoff value of 2000 ng/mL. The assay is designed for prescription use with a number of automated clinical chemistry analyzers.
Pointe Opiates 300 Reagent Set 1 x 1000 mL R1, 1 x 375 mL R2 The Pointe Opiates
Pointe Opiates 300 Reagent Set 1 x 1000 mL R1, 1 x 375 mL R2 The Pointe Opiates 300 Reagent Set is intended for the qualitative and semi-quantitative determination of opiates in human urine at a cutoff value of 300 ng/mL when calibrated against morphine. The assay is designed for prescription use with a number of automated clinical chemistry analyzers. This assay is for prescription use only.
Pointe Opiates 300 Reagent Set 1 x 100 mL R1, 1 x 37.5 mL R2 The Pointe Opiates
Pointe Opiates 300 Reagent Set 1 x 100 mL R1, 1 x 37.5 mL R2 The Pointe Opiates 300 Reagent Set is intended for the qualitative and semi-quantitative determination of opiates in human urine at a cutoff value of 300 ng/mL when calibrated against morphine. The assay is designed for prescription use with a number of automated clinical chemistry analyzers. This assay is for prescription use only.
Pointe Hydrocodone 300 Reagent Set 1 x 100 mL R1, 1 x 37.5 mL R2 The Pointe Hydr
Pointe Hydrocodone 300 Reagent Set 1 x 100 mL R1, 1 x 37.5 mL R2 The Pointe Hydrocodone 300 Reagent Set is intended for the qualitative and semi-quantitative determination of hydrocodone in human urine at a cutoff value of 300 ng/mL. The assay is designed for prescription use with a number of automated clinical chemistry analyzers.
Pointe Hydrocodone 100 Reagent Set 1 x 1000 mL R1, 1 x 375 mL R2 The Pointe Hydr
Pointe Hydrocodone 100 Reagent Set 1 x 1000 mL R1, 1 x 375 mL R2 The Pointe Hydrocodone 100 Reagent Set is intended for the qualitative and semi-quantitative determination of hydrocodone in human urine at a cutoff value of 100 ng/mL. The assay is designed for prescription use with a number of automated clinical chemistry analyzers.
Pointe Hydrocodone 100 Reagent Set 1 x 100 mL R1, 1 x 37.5 mL R2 The Pointe Hydr
Pointe Hydrocodone 100 Reagent Set 1 x 100 mL R1, 1 x 37.5 mL R2 The Pointe Hydrocodone 100 Reagent Set is intended for the qualitative and semi-quantitative determination of hydrocodone in human urine at a cutoff value of 100 ng/mL. The assay is designed for prescription use with a number of automated clinical chemistry analyzers.
Pointe Fentanyl (Qualitative) Reagent Set 1 x 1000 mL R1, 1 x 375 mL R2 The Poin
Pointe Fentanyl (Qualitative) Reagent Set 1 x 1000 mL R1, 1 x 375 mL R2 The Pointe Fentanyl Reagent Set is intended for the qualitative determination of norfentanyl in human urine at the cutoff value of 5 ng/mL when calibrated against norfentanyl. The assay is designed for prescription use with a number of automated clinical chemistry analyzers.
Pointe Fentanyl (Qualitative) Reagent Set 1 x 100 mL R1, 1 x 37.5 mL R2 The Poin
Pointe Fentanyl (Qualitative) Reagent Set 1 x 100 mL R1, 1 x 37.5 mL R2 The Pointe Fentanyl Reagent Set is intended for the qualitative determination of norfentanyl in human urine at the cutoff value of 5 ng/mL when calibrated against norfentanyl. The assay is designed for prescription use with a number of automated clinical chemistry analyzers.
Pointe Buprenorphine Reagent Set 1 x 1000 mL R1, 1 x 375 mL R2 The Pointe Bupren
Pointe Buprenorphine Reagent Set 1 x 1000 mL R1, 1 x 375 mL R2 The Pointe Buprenorphine Reagent Set is intended for the qualitative and semi-quantitative determination of norbuprenorphine (a buprenorphine metabolite) in human urine at a cutoff value of 5 ng/mL and 10 ng/mL. The assay is designed for prescription use with a number of automated clinical chemistry analyzers.
Pointe Buprenorphine Reagent Set 1 x 100 mL R1, 1 x 37.5 mL R2 The Pointe Bupren
Pointe Buprenorphine Reagent Set 1 x 100 mL R1, 1 x 37.5 mL R2 The Pointe Buprenorphine Reagent Set is intended for the qualitative and semi-quantitative determination of norbuprenorphine (a buprenorphine metabolite) in human urine at a cutoff value of 5 ng/mL and 10 ng/mL. The assay is designed for prescription use with a number of automated clinical chemistry analyzers.